{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T02:54:04Z","timestamp":1774061644916,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"\u201cla\u00a0Caixa\u201d Foundation, Barcelona"},{"name":"Alfonso Mart\u00edn Escudero Foundation, Madrid"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ejso.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T20:53:47Z","timestamp":1550523227000},"page":"1410-1416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer"],"prefix":"10.1016","volume":"45","author":[{"given":"Martina Aida","family":"Angeles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gw\u00e9na\u00ebl","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastien","family":"Cabarrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gis\u00e8le","family":"Balague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Mart\u00ednez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Gladieff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pomel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2019.02.018_bib1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ygyno.2004.01.029","article-title":"Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygyno.2010.12.328","article-title":"Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer","volume":"121","author":"Martinez","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/IGC.0000000000000041","article-title":"Prognostic relevance of celiac lymph node involvement in ovarian cancer","volume":"24","author":"Mart\u00ednez","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2019.02.018_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2019.02.018_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejso.2006.03.002","article-title":"Quantitative prognostic indices in peritoneal carcinomatosis","volume":"32","author":"Gilly","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2007.05.032","article-title":"A\u00a0new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model","volume":"107","author":"Aletti","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2019.02.018_bib10","series-title":"Maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum Era\u202f","first-page":"1248","volume":"vol.20","author":"Bristow","year":"2002"},{"key":"10.1016\/j.ejso.2019.02.018_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the arbeitsgemeinschaft gynaekologische onkologie studiengruppe ovarialkarzin","volume":"115","author":"Bois A Du","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2019.02.018_bib12","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"25","author":"Winter","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2016.03.015","article-title":"Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery","volume":"141","author":"Heitz","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/gyno.2001.6312","article-title":"What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2007.11.004","article-title":"Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer","volume":"108","author":"Salani","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib16","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","article-title":"A\u00a0model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2019.02.018_bib17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","article-title":"Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer","volume":"25","author":"Axtell","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib18","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1148\/rg.326125511","article-title":"Ovarian carcinomatosis: how the radiologist can help plan the surgical approach","volume":"32","author":"Nougaret","year":"2012","journal-title":"Radiographics"},{"key":"10.1016\/j.ejso.2019.02.018_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2013.01.024","article-title":"Advanced ovarian cancer: omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor","volume":"129","author":"Raspagliesi","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ygyno.2010.12.350","article-title":"Extended cytoreduction of tumor at the porta hepatis by an interdisciplinary team approach in patients with epithelial ovarian cancer","volume":"121","author":"Song","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygyno.2016.08.232","article-title":"Porta hepatis peritonectomy and hepato\u2013celiac lymphadenectomy in patients with stage IIIC\u2013IV ovarian cancer: diagnostic pathway, surgical technique and outcomes","volume":"143","author":"Tozzi","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib22","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-017-6005-1","article-title":"Hepatoceliac lymph node involvement in advanced ovarian cancer Patients\u202f: prognostic role and clinical considerations","author":"Gallotta","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2013.06.017","article-title":"Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182","volume":"130","author":"Rodriguez","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib24","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1245\/s10434-014-3558-0","article-title":"Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations","volume":"21","author":"Gallotta","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib25","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1245\/s10434-007-9565-7","article-title":"Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma","volume":"14","author":"Salani","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jso.21940","article-title":"Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resection","volume":"104","author":"Baiocchi","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/gyno.1995.0008","article-title":"Ovarian carcinoma metastases to gastrointestinal tract appear to spread like colon carcinoma: implications for surgical resection","volume":"59","author":"O'Hanlan","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib28","series-title":"Pictorial essay pathways of nodal cecum , ascending CT demonstration metastasis in carcinomas of the colon , and transverse Colon\u202f","author":"Mcdaniel","year":"1993"},{"key":"10.1016\/j.ejso.2019.02.018_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2535\/ofaj1936.77.6_189","article-title":"Long descending lymphatic pathway from the pancreaticoduodenal region to the para-aortic nodes: its laterality and topographical relationship with the celiac plexus","volume":"77","author":"Hirai","year":"2001","journal-title":"Okajimas Folia Anat Jpn"},{"key":"10.1016\/j.ejso.2019.02.018_bib30","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1200\/JCO.2017.35.15_suppl.5500","article-title":"LION: lymphadenectomy in ovarian neoplasms\u2014a prospective randomized AGO study group led gynecologic cancer intergroup trial","volume":"35","author":"Harter","year":"2017","journal-title":"J\u00a0Clin Oncol [Internet]"},{"key":"10.1016\/j.ejso.2019.02.018_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2009.11.022","article-title":"The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum","volume":"116","author":"Zivanovic","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib32","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1245\/s10434-015-5069-z","article-title":"Surgical complexity impact on survival after complete cytoreductive surgery for advanced ovarian cancer","volume":"23","author":"Martinez","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/aogs.13193","article-title":"Is there a revision needed of the current FIGO staging system?","volume":"96","author":"Menczer","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejso.2019.02.018_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2016.03.012","article-title":"Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer","volume":"141","author":"Prader","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039415","article-title":"Multi-center evaluation of post-operative morbidity and mortality after optimal cytoreductive surgery for advanced ovarian cancer","volume":"7","author":"Rafii","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2019.02.018_bib36","first-page":"63","article-title":"Nomogram for 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer","volume":"37","author":"Nieuwenhuyzen-de Boer","year":"2016","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2010.05.031","article-title":"The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas","volume":"119","author":"Chi","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.018_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S1478951508000497","article-title":"Quality of life among women after surgery for ovarian cancer","volume":"6","author":"Schulman-Green","year":"2008","journal-title":"Palliat Support Care"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319302896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319302896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:30:34Z","timestamp":1760059834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319302896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0748798319302896"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.02.018","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}